AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Senores Pharmaceuticals Ltd.

₹1318.4 +$491.75 (+59.49%)
NSE · 16 Oct 2026 09:59 UTC
Previous Close
₹1258.8
Day Range
₹1253.6₹1324.4
Year Range
₹706₹1599
Market Cap
60.72B
AVG Volume
293.14K
Trailing/Forward PE
46.32/26.98
PEG ratio
0.87
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
National Stock Exchange of IndiaIN
Revenue (INR) · TTM
02B4B6B8B25 Q125 Q225 Q325 Q426 Q1
SENORES.NS Revenue (INR) by quarter, trailing twelve months
PeriodRevenue (INR)
26 Q16.74B
25 Q46.24B
25 Q35.47B
25 Q24.85B
25 Q14.3B
Net Income (INR) · TTM
0500M1B1.5B25 Q125 Q225 Q325 Q426 Q1
SENORES.NS Net Income (INR) by quarter, trailing twelve months
PeriodNet Income (INR)
26 Q11.26B
25 Q41.15B
25 Q31.02B
25 Q2871.2M
25 Q1675.8M
Operating Income (INR) · TTM
0500M1B1.5B2B25 Q125 Q225 Q325 Q426 Q1
SENORES.NS Operating Income (INR) by quarter, trailing twelve months
PeriodOperating Income (INR)
26 Q11.7B
25 Q41.54B
25 Q31.3B
25 Q21.05B
25 Q1832M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (INR) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Senores Pharmaceuticals Ltd.
SENORES.NS
Stockpicker

Video analysis: SENORES.NS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: SENORES.NS

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.